Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
This article examines Why Do Stablecoins Fail, focusing on reserve adequacy, liquidity mismanagement, and governance gaps that threaten peg stability.
18,006 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
As federal agencies debate when a car becomes a weapon, lawmakers and taxpayers face rising costs, lawsuits, and ques...
Goldman Sachs exited all XRP and SOL ETF positions in Q1 2026, according to the latest 13F filing. The move shifts th...
Two leading firms cut Microsoft price targets ahead of fiscal Q4, but both retain bullish ratings as Copilot and Azur...
Investors are watching a niche player circle the AI data-center space. This small crypto miner is shifting gears, spa...
When the market teeters, the smartest investors lean on history and discipline. Discover a single, proven move you ca...
Nike stands as a global powerhouse, but recent pressure has investors asking, should Nike stock? This guide lays out ...
Policy clarity clears the path for road ahead build-to-rent projects, lifting investor confidence. Still, the pace of...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Ethereum isn't resting on its laurels. A bold plan for 2029 aims to streamline the network, cut costs, and attract bu...
Home Depot's Q1 2026 results provide a window into consumer demand, mix shifts, and profitability. This article break...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...